SEARCH

SEARCH BY CITATION

References

  • Annaert W. G., Levesque L., Craessaerts K., Dierinck I., Snellings G., Westaway D., George-Hyslop P. S., Cordell B., Fraser P. and De Strooper B. (1999) Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147, 277294.
  • Annaert W. G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., Craessaerts K. and De Strooper B. (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579589.
  • Arduengo P. M., Appleberry O. K., Chuang P. and L'Hernault S. W. (1998) The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis. J. Cell Sci. 111, 36453654.
  • Arendash G. W., King D. L., Gordon M. N., Morgan D., Hatcher J. M., Hope C. E. and Diamond D. M. (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891, 4253.
  • Baulac S., LaVoie M. J., Kimberly W. T., Strahle J., Wolfe M. S., Selkoe D. J. and Xia W. (2003) Functional gamma-secretase complex assembly in Golgi/trans–Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol. Dis. 14, 194204.
  • Baumann K., Paganetti P. A., Sturchler-Pierrat C., Wong C., Hartmann H., Cescato R., Frey P., Yankner B. A., Sommer B. and Staufenbiel M. (1997) Distinct processing of endogenous and overexpressed recombinant presenilin 1. Neurobiol. Aging 18, 181189.
  • Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J. and Haass C. (1997) Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1, 149159.
  • Beher D., Elle C., Underwood J., Davis J. B., Ward R., Karran E., Masters C. L., Beyreuther K. and Multhaup G. (1999) Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain. J. Neurochem. 72, 15641573.
  • Beher D., Wrigley J. D., Nadin A., Evin G., and Masters C. L., Harrison T., Castro J. L. and Shearman M. S. (2001) Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma-secretase inhibitor: implications for presenilin biology. J Biol. Chem. 276, 45 39445 402.
  • Beher D., Fricker M., Nadin A., Clarke E. E., Wrigley J. D., Li Y. M., Culvenor J. G., Masters C. L., Harrison T. and Shearman M. S. (2003) In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand. Biochemistry 42, 81338142.
  • Benkovic S. A., McGowan E. M., Rothwell N. J., Hutton M., Morgan D. G. and Gordon M. N. (1997) Regional and cellular localization of presenilin-2 RNA in rat and human brain. Exp. Neurol. 145, 555564.
  • Berezovska O., Xia M. Q., Page K., Wasco W., Tanzi R. E. and Hyman B. T. (1997) Developmental regulation of presenilin mRNA expression parallels notch expression. J. Neuropathol. Exp. Neurol. 56, 4044.
  • Berezovska O., Xia M. Q. and Hyman B. T. (1998) Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 738745.
  • Berezovska O., Frosch M., McLean P. et al. (1999) The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Brain Res. Mol. Brain Res. 69, 273280.
  • Berezovska O., Jack C., McLean P., Aster J. C., Hicks C., Xia W., Wolfe M. S., Weinmaster G., Selkoe D. J. and Hyman B. T. (2000a) Rapid Notch1 nuclear translocation after ligand binding depends on presenilin-associated gamma-secretase activity. Ann. NY Acad. Sci. 920, 223226.
  • Berezovska O., Jack C., McLean P. et al. (2000b) Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. J. Neurochem. 75, 583593.
  • Bergman A., Laudon H., Winblad B., Lundkvist J. and Naslund J. (2004a) The extreme C terminus of presenilin 1 is essential for gamma-secretase complex assembly and activity. J. Biol. Chem. 279, 45 56445 572.
  • Bergman A., Hansson E. M., Pursglove S. E., Farmery M. R., Lannfelt L., Lendahl U., Lundkvist J. and Naslund J. (2004b) Pen-2 is sequestered in the endoplasmic reticulum and subjected to ubiquitylation and proteasome-mediated degradation in the absence of presenilin. J. Biol. Chem. 279, 16 74416 753.
  • Blanchard V., Czech C., Bonici B., Clavel N., Gohin M., Dalet K., Revah F., Pradier L., Imperato A. and Moussaoui S. (1997) Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein. Brain Res. 758, 209217.
  • Blaumueller C. M., Qi H., Zagouras P. and Artavanis-Tsakonas S. (1997) Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell 90, 281291.
  • Borchelt D. R., Ratovitski T., Van Lare J., Lee M. K., Gonzales V., Jenkins N. A., Copeland N. G., Price D. L. and Sisodia S. S. (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939945.
  • Borg J. P., Yang Y., De Taddeo-Borg M., Margolis B. and Turner R. S. (1998) The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J. Biol. Chem. 273, 14 76114 766.
  • Brockhaus M., Grunberg J., Rohrig S., Loetscher H., Wittenburg N., Baumeister R., Jacobsen H. and Haass C. (1998) Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 9, 14811486.
  • Brown M. S., Ye J., Rawson R. B. and Goldstein J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391398.
  • Brunkan A. L., Martinez M., Wang J., Walker E. S. and Goate A. M. (2005) A domain at the C-terminus of PS1 is required for presenilinase and gamma-secretase activities. J. Neurochem. 92, 11581169.
  • Busciglio J., Gabuzda D. H., Matsudaira P. and Yankner B. A. (1993) Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 20922096.
  • Buxbaum J. D., Choi E. K., Luo Y., Lilliehook C., Crowley A. C., Merriam D. E. and Wasco W. (1998) Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4, 11771181.
  • Campbell W. A., Iskandar M. K., Reed M. L. and Xia W. (2002) Endoproteolysis of presenilin in vitro: inhibition by gamma-secretase inhibitors. Biochemistry 41, 33723379.
  • Campbell W. A., Reed M. L., Strahle J., Wolfe M. S. and Xia W. (2003) Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from gamma-secretase. J. Neurochem. 85, 15631574.
  • Cao X. and Sudhof T. C. (2001) A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115120.
  • Cao X. and Sudhof T. C. (2004) Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 279, 24 60124 611.
  • Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D. J. and Haass C. (1998) The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100–150-kDa molecular mass complex. J. Biol. Chem. 273, 32053211.
  • Cervantes S., Gonzalez-Duarte R. and Marfany G. (2001) Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease. FEBS Lett. 505, 8186.
  • Cervantes S., Saura C. A., Pomares E., Gonzalez-Duarte R. and Marfany G. (2004) Functional implications of the presenilin dimerization. Reconstitution of gamma-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins. J. Biol. Chem. 279, 36 51936 529.
  • Chen F., Yang D. S., Petanceska S. et al. (2000a) Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells. J. Biol. Chem. 275, 36 79436 802.
  • Chen F., Yu G., Arawaka S. et al. (2001) Nicastrin binds to membrane-tethered Notch. Nat. Cell Biol. 3, 751754.
  • Chen F., Tandon A., Sanjo N. et al. (2003) Presenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in Mammalian brain. J. Biol. Chem. 278, 19 97419 979.
  • Chen G., Chen K. S., Knox J. et al. (2000b) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975979.
  • Choi E. K., Zaidi N. F., Miller J. S., Crowley A. C., Merriam D. E., Lilliehook C., Buxbaum J. D. and Wasco W. (2001) Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2. J. Biol. Chem. 276, 19 19719 204.
  • Chung H. M. and Struhl G. (2001) Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat. Cell Biol. 3, 11291132.
  • Citron M., Westaway D., Xia W. et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 6772.
  • Citron M., Eckman C. B., Diehl T. S., Corcoran C., Ostaszewski B. L., Xia W., Levesque G., St George Hyslop P., Younkin S. G. and Selkoe D. J. (1998) Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol. Dis. 5, 107116.
  • Crook R. (2000) Alzheimer Research Forum Presenilin-1 Diagram [www document] . URL http://www.alzforum.org/res/com/mut/pre/diagram1.asp[accessed during January 2005].
  • Cruts M. and Rademakers R. (2004) Alzheimer Disease & Frontotemporal Dementia Mutation Database [www document]. URL http://www.molgen.ua.ac.be/ADMutations/default.cfm[accesssed during January 2005].
  • Crystal A. S., Morais V. A., Pierson T. C., Pijak D. S., Carlin D., Lee V. M. and Doms R. W. (2003) Membrane topology of gamma-secretase component PEN-2. J. Biol. Chem. 278, 20 11720 123.
  • Crystal A. S., Morais V. A., Fortna R. R., Carlin D., Pierson T. C., Wilson C. A., Lee V. M. and Doms R. W. (2004) Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation. Biochemistry 43, 35553563.
  • Culvenor J. G., Maher F., Evin G. et al. (1997) Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J. Neurosci. Res. 49, 719731.
  • Culvenor J. G., Ilaya N. T., Ryan M. T., Canterford L., Hoke D. E., Williamson N. A., McLean C. A., Masters C. L. and Evin G. (2004) Characterization of presenilin complexes from mouse and human brain using Blue Native gel electrophoresis reveals high expression in embryonic brain and minimal change in complex mobility with pathogenic presenilin mutations. Eur. J. Biochem. 271, 375385.
  • Cummings J. L. (2004) Alzheimer's disease. N. Engl. J. Med. 351, 5667.
  • Cupers P., Orlans I., Craessaerts K., Annaert W. and De Strooper B. (2001) The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78, 11681178.
  • Davis J. A., Naruse S., Chen H., Eckman C., Younkin S., Price D. L., Borchelt D. R., Sisodia S. S. and Wong P. C. (1998) An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20, 603609.
  • De Jonghe C., Esselens C., Kumar-Singh S., Craessaerts K., Serneels S., Checler F., Annaert W., Van Broeckhoven C. and De Strooper B. (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 16651671.
  • De Strooper B., Beullens M., Contreras B. et al. (1997) Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272, 35903598.
  • De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K. and Van Leuven F. (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387390.
  • De Strooper B., Annaert W., Cupers P. et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518522.
  • Dewji N. N. and Singer S. J. (1997) The seven-transmembrane spanning topography of the Alzheimer disease-related presenilin proteins in the plasma membranes of cultured cells. Proc. Natl Acad. Sci. USA 94, 14 02514 030.
  • Dewji N. N., Valdez D. and Singer S. J. (2004) The presenilins turned inside out: implications for their structures and functions. Proc. Natl Acad. Sci. USA 101, 10571062.
  • Doan A., Thinakaran G., Borchelt D. R. et al. (1996) Protein topology of presenilin 1. Neuron 17, 10231030.
  • Dodart J. C., Meziane H., Mathis C., Bales K. R., Paul S. M. and Ungerer A. (1999) Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113, 982990.
  • Donoviel D. B., Hadjantonakis A. K., Ikeda M., Zheng H., Hyslop P. S. and Bernstein A. (1999) Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 13, 28012810.
  • Dovey H. F., Suomensaari-Chrysler S., Lieberburg I., Sinha S. and Keim P. S. (1993) Cells with a familial Alzheimer's disease mutation produce authentic beta-peptide. Neuroreport 4, 10391042.
  • Duff K., Eckman C., Zehr C. et al. (1996) Increased amyloid-beta42 (43) in brains of mice expressing mutant presenilin 1. Nature 383, 710713.
  • Edbauer D., Winkler E., Haass C. and Steiner H. (2002) Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc. Natl Acad. Sci. USA 99, 86668671.
  • Edbauer D., Winkler E., Regula J. T., Pesold B., Steiner H. and Haass C. (2003) Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486488.
  • Eriksen J. L., Sagi S. A., Smith T. E. et al. (2003) NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 112, 440449.
  • Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D. and Ward P. J. (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 11221124.
  • Esler W. P., Kimberly W. T., Ostaszewski B. L., Diehl T. S., Moore C. L., Tsai J. Y., Rahmati T., Xia W., Selkoe D. J. and Wolfe M. S. (2000) Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat. Cell Biol. 2, 428434.
  • Esler W. P., Kimberly W. T., Ostaszewski B. L., Ye W., Diehl T. S., Selkoe D. J. and Wolfe M. S. (2002a) Activity-dependent isolation of the presenilin-gamma-secretase complex reveals nicastrin and a gamma substrate. Proc. Natl Acad. Sci. USA 99, 27202725.
  • Esler W. P., Das C., Campbell W. A. et al. (2002b) Amyloid-lowering isocoumarins are not direct inhibitors of gamma-secretase. Nat. Cell Biol. 4, E110E112.
  • Evin G., Sharples R. A., Weidemann A., Reinhard F. B., Carbone V., Culvenor J. G., Holsinger R. M., Sernee M. F., Beyreuther K. and Masters C. L. (2001) Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease. Biochemistry 40, 83598368.
  • Fortna R. R., Crystal A. S., Morais V. A., Pijak D. S., Lee V. M. and Doms R. W. (2004) Membrane topology and nicastrin-enhanced endoproteolysis of APH-1, a component of the gamma-secretase complex. J. Biol. Chem. 279, 36853693.
  • Fraering P. C., LaVoie M. J., Ye W., Ostaszewski B. L., Kimberly W. T., Selkoe D. J. and Wolfe M. S. (2004) Detergent-dependent dissociation of active gamma–secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43, 323333.
  • Francis R., McGrath G., Zhang J. et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 8597.
  • Friedmann E., Lemberg M. K., Weihofen A., Dev K. K., Dengler U., Rovelli G. and Martoglio B. (2004) Consensus analysis of signal Peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J. Biol. Chem. 279, 50 79050 798.
  • Gao Y. and Pimplikar S. W. (2001) The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl Acad. Sci. USA 98, 1497914984.
  • Glenner G. G. and Wong C. W. (1984a) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 11311135.
  • Glenner G. G. and Wong C. W. (1984b) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Gorevic P. D., Goni F., Pons-Estel B., Alvarez F., Peress N. S. and Frangione B. (1986) Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies. J. Neuropathol. Exp. Neurol. 45, 647664.
  • Goutte C., Hepler W., Mickey K. M. and Priess J. R. (2000) aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127, 24812492.
  • Goutte C., Tsunozaki M., Hale V. A. and Priess J. R. (2002) APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl Acad. Sci. USA 99, 775779.
  • Grigorenko A. P., Moliaka Y. K., Korovaitseva G. I. and Rogaev E. I. (2002) Novel class of polytopic proteins with domains associated with putative protease activity. Biochemistry (Moscow ) 67, 826835.
  • Grunberg J., Walter J., Loetscher H., Deuschle U., Jacobsen H. and Haass C. (1998a) Alzheimer's disease associated presenilin-1 holoprotein and its 18–20 kDa C-terminal fragment are death substrates for proteases of the caspase family. Biochemistry 37, 22632270.
  • Grunberg J., Walter J., Eckman C., Capell A., Schindzielorz A., Younkin S., Mehta N., Hardy J. and Haass C. (1998b) Truncated presenilin 2 derived from differentially spliced mRNA does not affect the ratio of amyloid beta-peptide 1–42/1–40. Neuroreport 9, 32933299.
  • Gu Y., Misonou H., Sato T., Dohmae N., Takio K. and Ihara Y. (2001) Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J. Biol. Chem. 276, 35 23535 238.
  • Gu Y., Chen F., Sanjo N. et al. (2003) APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes. J. Biol. Chem. 278, 73747380.
  • Guo Y., Livne-Bar I., Zhou L. and Boulianne G. L. (1999) Drosophila presenilin is required for neuronal differentiation and affects notch subcellular localization and signaling. J. Neurosci. 19, 84358442.
  • Haass C. and Selkoe D. J. (1993) Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75, 10391042.
  • Haass C., Schlossmacher M. G., Hung A. Y. et al. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322325.
  • Hasegawa H., Sanjo N., Chen F. et al. (2004) Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. J. Biol. Chem. 279, 46 45546 463.
  • Hebert S. S., Godin C. and Levesque G. (2003a) Oligomerization of human presenilin-1 fragments. FEBS Lett. 550, 3034.
  • Hebert S. S., Godin C., Tomiyama T., Mori H. and Levesque G. (2003b) Dimerization of presenilin-1 in vivo: suggestion of novel regulatory mechanisms leading to higher order complexes. Biochem. Biophys. Res. Commun. 301, 119126.
  • Hecimovic S., Wang J., Dolios G., Martinez M., Wang R. and Goate A. M. (2004) Mutations in APP have independent effects on Abeta and CTFgamma generation. Neurobiol. Dis. 17, 205218.
  • Herreman A., Hartmann D., Annaert W. et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl Acad. Sci. USA 96, 11 87211 877.
  • Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L. and De Strooper B. (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2, 461462.
  • Herreman A., Van Gassen G., Bentahir M., Nyabi O., Craessaerts K., Mueller U., Annaert W. and De Strooper B. (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J. Cell Sci. 116, 11271136.
  • Holcomb L., Gordon M. N., McGowan E. et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97100.
  • Hu Y. and Fortini M. E. (2003) Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J. Cell Biol. 161, 685690.
  • Hu Y., Ye Y. and Fortini M. E. (2002) Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor. Dev. Cell 2, 6978.
  • Ikeuchi T. and Sisodia S. S. (2003) The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent ‘gamma-secretase’ cleavage. J. Biol. Chem. 278, 77517754.
  • Jacobsen H., Reinhardt D., Brockhaus M., Bur D., Kocyba C., Kurt H., Grim M. G., Baumeister R. and Loetscher H. (1999) The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on abeta42 amyloid peptide formation. J. Biol. Chem. 274, 35 23335 239.
  • Jarriault S., Brou C., Logeat F., Schroeter E. H., Kopan R. and Israel A. (1995) Signalling downstream of activated mammalian Notch. Nature 377, 355358.
  • Jo D. G., Chang J. W., Hong H. S., Mook-Jung I. and Jung Y. K. (2003) Contribution of presenilin/gamma-secretase to calsenilin-mediated apoptosis. Biochem. Biophys. Res. Commun. 305, 6266.
  • Kaether C., Lammich S., Edbauer D., Ertl M., Rietdorf J., Capell A., Steiner H. and Haass C. (2002) Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J. Cell Biol. 158, 551561.
  • Kang D. E., Soriano S., Frosch M. P., Collins T., Naruse S., Sisodia S. S., Leibowitz G., Levine F. and Koo E. H. (1999) Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J. Neurosci. 19, 42294237.
  • Kang D. E., Soriano S., Xia X., Eberhart C. G., De Strooper B., Zheng H. and Koo E. H. (2002) Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110, 751762.
  • Killick R., Pollard C. C., Asuni A. A. et al. (2001) Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. J. Biol. Chem. 276, 48 55448 561.
  • Kim D. Y., Ingano L. A. and Kovacs D. M. (2002) Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. J. Biol. Chem. 277, 49 97649 981.
  • Kim S. H. and Sisodia S. S. (2004) A sequence within the first transmembrane domain of PEN-2 is critical for PEN-2-mediated endoproteolysis of presenilin 1. J Biol Chem . e-published November 10.
  • Kim T. W., Pettingell W. H., Jung Y. K., Kovacs D. M. and Tanzi R. E. (1997a) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373376.
  • Kim T. W., Pettingell W. H., Hallmark O. G., Moir R. D., Wasco W. and Tanzi R. E. (1997b) Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272, 11 00611 010.
  • Kimberly W. T., Xia W., Rahmati T., Wolfe M. S. and Selkoe D. J. (2000) The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J. Biol. Chem. 275, 31733178.
  • Kimberly W. T., Zheng J. B., Guenette S. Y. and Selkoe D. J. (2001) The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276, 40 28840 292.
  • Kimberly W. T., LaVoie M. J., Ostaszewski B. L., Ye W., Wolfe M. S. and Selkoe D. J. (2002) Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. J. Biol. Chem. 277, 35 11335 117.
  • Kimberly W. T., LaVoie M. J., Ostaszewski B. L., Ye W., Wolfe M. S. and Selkoe D. J. (2003) Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl Acad. Sci. USA 100, 63826387.
  • Kinoshita A., Whelan C. M., Berezovska O. and Hyman B. T. (2002) The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277, 28 53028 536.
  • Kirschenbaum F., Hsu S. C., Cordell B. and McCarthy J. V. (2001) Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling. J. Biol. Chem. 276, 73667375.
  • Kulic L., Walter J., Multhaup G., Teplow D. B., Baumeister R., Romig H., Capell A., Steiner H. and Haass C. (2000) Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch. Proc. Natl Acad. Sci. USA 97, 59135918.
  • Kurt M. A., Davies D. C., Kidd M., Duff K., Rolph S. C., Jennings K. H. and Howlett D. R. (2001) Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp. Neurol. 171, 5971.
  • Kwok J. B., Halliday G. M., Brooks W. S. et al. (2003) Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy. J. Biol. Chem. 278, 67486754.
  • Lah J. J., Heilman C. J., Nash N. R., Rees H. D., Yi H., Counts S. E. and Levey A. I. (1997) Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17, 19711980.
  • Lai M. T., Chen E., Crouthamel M. C. et al. (2003) Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J. Biol. Chem. 278, 22 47522 481.
  • Lammich S., Okochi M., Takeda M., Kaether C., Capell A., Zimmer A. K., Edbauer D., Walter J., Steiner H. and Haass C. (2002) Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J. Biol. Chem. 277, 44 75444 759.
  • Laudon H., Karlstrom H., Mathews P. M., Farmery M. R., Gandy S. E., Lundkvist J., Lendahl U. and Naslund J. (2004a) Functional domains in presenilin 1: the Tyr-288 residue controls gamma-secretase activity and endoproteolysis. J. Biol. Chem. 279, 23 92523 932.
  • Laudon H., Mathews P. M., Karlstrom H. et al. (2004b) Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein. J. Neurochem. 89, 4453.
  • LaVoie M. J., Fraering P. C., Ostaszewski B. L., Ye W., Kimberly W. T., Wolfe M. S. and Selkoe D. J. (2003) Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J. Biol. Chem. 278, 37 21337 222.
  • Lee M. K., Slunt H. H., Martin L. J., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo E., Price D. L. and Sisodia S. S. (1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16, 75137525.
  • Lee S. F., Shah S., Li H., Yu C., Han W. and Yu G. (2002) Mammalian APH-1 interacts with presenilin and nicastrin, and is required for intramembrane proteolysis of APP and Notch. J. Biol. Chem. 277, 45 01345 019.
  • Lee S. F., Shah S., Yu C. et al. (2004) A conserved GXXXG motif in APH-1 is critical for assembly and activity of the {gamma}-secretase complex. J. Biol. Chem. 279, 41444152.
  • Leem J. Y., Vijayan S., Han P., Cai D., Machura M., Lopes K. O., Veselits M. L., Xu H. and Thinakaran G. (2002a) Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 277, 19 23619 240.
  • Leem J. Y., Saura C. A., Pietrzik C. et al. (2002b) A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11, 6482.
  • Lehmann S., Chiesa R. and Harris D. A. (1997) Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272, 1204712051.
  • Leimer U., Lun K., Romig H., Walter J., Grunberg J., Brand M. and Haass C. (1999) Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 38, 13 60213 609.
  • Leissring M. A., Yamasaki T. R., Wasco W., Buxbaum J. D., Parker I. and LaFerla F. M. (2000) Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl Acad. Sci. USA 97, 85908593.
  • Lemberg M. K. and Martoglio B. (2002) Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cell 10, 735744.
  • Lendon C. L., Ashall F. and Goate A. M. (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277, 825831.
  • Levesque G., Yu G., Nishimura M. et al. (1999) Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J. Neurochem. 72, 9991008.
  • Levitan D. and Greenwald I. (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351354.
  • Levitan D. and Greenwald I. (1998) LIN-12 protein expression and localization during vulval development in C. elegans. Development 125, 31013109.
  • Levitan D., Doyle T. G., Brousseau D., Lee M. K., Thinakaran G., Slunt H. H., Sisodia S. S. and Greenwald I. (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 93, 14 94014 944.
  • Levitan D., Yu G., St George Hyslop P. and Goutte C. (2001a) APH-2/nicastrin functions in LIN-12/Notch signaling in the Caenorhabditis elegans somatic gonad. Dev. Biol. 240, 654661.
  • Levitan D., Lee J., Song L., Manning R., Wong G., Parker E. and Zhang L. (2001b) PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc. Natl Acad. Sci. USA 98, 12 18612 190.
  • Li T., Ma G., Cai H., Price D. L. and Wong P. C. (2003) Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. J. Neurosci. 23, 32723277.
  • Li T., Ma G., Peck J., Wen H., Price D. L. and Wong P. C. (2004) Characterization of [ggr]-secretase complex: analysis of Aph-1b deficient mice. Neurobiol. Aging 25, S63.
  • Li, X. and Greenwald, I.(1996) Membrane topology of the C. elegans SEL-12 presenilin. Neuron 17, 10151021.
  • Li X. and Greenwald I. (1997) HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl Acad. Sci. USA 94, 12 20412 209.
  • Li X. and Greenwald I. (1998) Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc. Natl Acad. Sci. USA 95, 71097114.
  • Li Y. M., Xu M., Lai M. T. et al. (2000) Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689694.
  • Lleo A., Berezovska O., Ramdya P., Fukumoto H., Raju S., Shah T. and Hyman B. T. (2003) Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression. J. Biol. Chem. 278, 47 37047 375.
  • Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grunberg J., Haass C. and Jacobsen H. (1997) Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272, 20 65520 659.
  • Logeat F., Bessia C., Brou C., LeBail O., Jarriault S., Seidah N. G. and Israel A. (1998) The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl Acad. Sci. USA 95, 81088112.
  • Lopez-Schier H. and St Johnston D. (2002) Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev. Cell 2, 7989.
  • Luo W. J., Wang H., Li H., Kim B. S., Shah S., Lee H. J., Thinakaran G., Kim T. W., Yu G. and Xu H. (2003) PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J. Biol. Chem. 278, 78507854.
  • Marambaud P., Shioi J., Serban G. et al. (2002) A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21, 19481956.
  • Martoglio B. and Golde T. E. (2003) Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs. Hum. Mol. Genet. 12, R201R206.
  • Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 42454249.
  • May P., Reddy Y. K. and Herz J. (2002) Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18 73618 743.
  • McGeer P. L., Schulzer M. and McGeer E. G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425432.
  • McGowan E., Sanders S., Iwatsubo T. et al. (1999) Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6, 231244.
  • McLoughlin D. M., Irving N. G., Brownlees J., Brion J. P., Leroy K. and Miller C. C. (1999) Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. Eur. J. Neurosci. 11, 19881994.
  • Moehlmann T., Winkler E., Xia X. et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc. Natl Acad. Sci. USA 99, 80258030.
  • Morihara T., Chu T., Ubeda O., Beech W. and Cole G. M. (2002) Selective inhibition of Abeta42 production by NSAID R-enantiomers. J. Neurochem. 83, 10091012.
  • Moussaoui S., Czech C., Pradier L., Blanchard V., Bonici B., Gohin M., Imperato A. and Revah F. (1996) Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett. 383, 219222.
  • Mumm J. S., Schroeter E. H., Saxena M. T., Griesemer A., Tian X., Pan D. J., Ray W. J. and Kopan R. (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197206.
  • Murakami D., Okamoto I., Nagano O., Kawano Y., Tomita T., Iwatsubo T., De Strooper B., Yumoto E. and Saya H. (2003) Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene 22, 15111516.
  • Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X., Yasutake K., Nihonmatsu N., Wolozin B. and Takashima A. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Lett. 433, 7377.
  • Murphy M. P., Uljon S. N., Fraser P. E. et al. (2000) Presenilin 1 regulates pharmacologically distinct gamma-secretase activities. Implications for the role of presenilin in gamma-secretase cleavage. J. Biol. Chem. 275, 26 27726 284.
  • Nakai T., Yamasaki A., Sakaguchi M., Kosaka K., Mihara K., Amaya Y. and Miura S. (1999) Membrane topology of Alzheimer's disease-related presenilin 1. Evidence for the existence of a molecular species with a seven membrane-spanning and one membrane-embedded structure. J. Biol. Chem. 274, 23 64723 658.
  • Nakajima M., Shimizu T. and Shirasawa T. (2000) Notch-1 activation by familial Alzheimer's disease (FAD)-linked mutant forms of presenilin-1. J. Neurosci. Res. 62, 311317.
  • Nakamura K., Manabe T., Watanabe M. et al. (2001) Enhancement of hippocampal LTP, reference memory and sensorimotor gating in mutant mice lacking a telencephalon-specific cell adhesion molecule. Eur. J. Neurosci. 13, 179189.
  • Naruse S., Thinakaran G., Luo J. J. et al. (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 12131221.
  • Ni C. Y., Murphy M. P., Golde T. E. and Carpenter G. (2001) gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 21792181.
  • Nishimura M., Yu G., Levesque G. et al. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat. Med. 5, 164169.
  • Noll E., Medina M., Hartley D., Zhou J., Perrimon N. and Kosik K. S. (2000) Presenilin affects arm/beta-catenin localization and function in Drosophila. Dev. Biol. 227, 450464.
  • Nowotny P., Gorski S. M., Han S. W., Philips K., Ray W. J., Nowotny V., Jones C. J., Clark R. F., Cagan R. L. and Goate A. M. (2000) Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin. Mol. Cell Neurosci. 15, 8898.
  • Nyborg A. C., Kornilova A. Y., Jansen K., Ladd T. B., Wolfe M. S. and Golde T. E. (2004) Signal peptide peptidase forms a homodimer that is labeled by an active site directed γ-secretase inhibitor. J. Biol. Chem. 279, 15 13315 160.
  • Octave J. N., Essalmani R., Tasiaux B., Menager J., Czech C. and Mercken L. (2000) The role of presenilin-1 in the gamma-secretase cleavage of the amyloid precursor protein of Alzheimer's disease. J. Biol. Chem. 275, 15251528.
  • Okochi M., Steiner H., Fukumori A., Tanii H., Tomita T., Tanaka T., Iwatsubo T., Kudo T., Takeda M. and Haass C. (2002) Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J. 21, 54085416.
  • Oyama F., Sawamura N., Kobayashi K. et al. (1998) Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain. J. Neurochem. 71, 313322.
  • Palacino J. J., Berechid B. E., Alexander P., Eckman C., Younkin S., Nye J. S. and Wolozin B. (2000) Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cells. J. Biol. Chem. 275, 215222.
  • Parks A. L., Klueg K. M., Stout J. R. and Muskavitch M. A. (2000) Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 127, 13731385.
  • Perez-Tur J., Froelich S., Prihar G. et al. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297301.
  • Petanceska S. S., Seeger M., Checler F. and Gandy S. (2000) Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway. J. Neurochem. 74, 18781884.
  • Petit A., Bihel F., Alves da Costa C., Pourquie O., Checler F. and Kraus J. L. (2001) New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat. Cell Biol. 3, 507511.
  • Podlisny M. B., Citron M., Amarante P. et al. (1997) Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol. Dis. 3, 325337.
  • Ponting C. P., Hutton M., Nyborg A., Baker M., Jansen K. and Golde T. E. (2002) Identification of a novel family of presenilin homologues. Hum. Mol. Genet. 11, 10371044.
  • Prihar G., Verkkoniem A., Perez-Tur J. et al. (1999) Alzheimer disease PS-1 exon 9 deletion defined. Nat. Med. 5, 1090.
  • Prokop S., Shirotani K., Edbauer D., Haass C. and Steiner H. (2004) Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J. Biol. Chem. 279, 23 25523 261.
  • Qian S., Jiang P., Guan X. M., Singh G., Trumbauer M. E., Yu H., Chen H. Y., Van de Ploeg L. H. and Zheng H. (1998) Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1–42/43 expression. Neuron 20, 611617.
  • Ramdya P., Skoch J., Bacskai B. J., Hyman B. T. and Berezovska O. (2003) Activated Notch1 associates with a presenilin-1/gamma-secretase docking site. J. Neurochem. 87, 843850.
  • Rand M. D., Grimm L. M., Artavanis-Tsakonas S., Patriub V., Blacklow S. C., Sklar J. and Aster J. C. (2000) Calcium depletion dissociates and activates heterodimeric notch receptors. Mol. Cell Biol. 20, 18251835.
  • Ratovitski T., Slunt H. H., Thinakaran G., Price D. L., Sisodia S. S. and Borchelt D. R. (1997) Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem. 272, 24 53624 541.
  • Ray W. J., Yao M., Nowotny P., Mumm J., Zhang W., Wu J. Y., Kopan R. and Goate A. M. (1999a) Evidence for a physical interaction between presenilin and Notch. Proc. Natl Acad. Sci. USA 96, 32633268.
  • Ray W. J., Yao M., Mumm J., Schroeter E. H., Saftig P., Wolfe M., Selkoe D. J., Kopan R. and Goate A. M. (1999b) Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch. J. Biol. Chem. 274, 36 80136 807.
  • Rogaev E. I., Sherrington R., Rogaeva E. A. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775778.
  • Sagi S. A., Weggen S., Eriksen J., Golde T. E. and Koo E. H. (2003) The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production. J. Biol. Chem. 278, 31 82531 830.
  • Sastre M., Turner R. S. and Levy E. (1998) X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion. J. Biol. Chem. 273, 22 35122 357.
  • Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M. M., Teplow D. B. and Haass C. (2001) Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835841.
  • Saura C. A., Tomita T., Davenport F., Harris C. L., Iwatsubo T. and Thinakaran G. (1999) Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing. J. Biol. Chem. 274, 13 81813 823.
  • Saura C. A., Tomita T., Soriano S., Takahashi M., Leem J. Y., Honda T., Koo E. H., Iwatsubo T. and Thinakaran G. (2000) The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants. J. Biol. Chem. 275, 17 13617 142.
  • Scheuner D., Eckman C., Jensen M. et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864870.
  • Schroeter E. H., Kisslinger J. A. and Kopan R. (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382386.
  • Schroeter E. H., Ilagan M. X., Brunkan A. L. et al. (2003) A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc. Natl Acad. Sci. USA 100, 13 07513 080.
  • Schwarzman A. L., Singh N., Tsiper M., Gregori L., Dranovsky A., Vitek M. P., Glabe C. G., St George-Hyslop P. H. and Goldgaber D. (1999) Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc. Natl Acad. Sci. USA 96, 79327937.
  • Seeger M., Nordstedt C., Petanceska S. et al. (1997) Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc. Natl Acad. Sci. USA 94, 50905094.
  • Seiffert D., Bradley J. D., Rominger C. M. et al. (2000) Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J. Biol. Chem. 275, 34 08634 091.
  • Selkoe D. J., Abraham C. R., Podlisny M. B. and Duffy L. K. (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 18201834.
  • Serneels L., Dejaegere T., Craessaerts K., Horre K., Jorissen E., Tousseyn T., Hebert S., Coolen M., Martens G., Zwijsen A., Annaert W., Hartmann D. and De Strooper B. (2005) Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo. Proc Natl Acad Sci USA 102, 17191724.
  • Seubert P., Oltersdorf T., Lee M. G. et al. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260263.
  • Shearman M. S., Beher D., Clarke E. E., Lewis H. D., Harrison T., Hunt P., Nadin A., Smith A. L., Stevenson G. and Castro J. L. (2000) L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry 39, 86988704.
  • Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J. and Tonegawa S. (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629639.
  • Sherrington R., Rogaev E. I., Liang Y. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754760.
  • Shirotani K., Takahashi K., Ozawa K., Kunishita T. and Tabira T. (1997) Determination of a cleavage site of presenilin 2 protein in stably transfected SH-SY5Y human neuroblastoma cell lines. Biochem. Biophys. Res. Commun. 240, 728731.
  • Shirotani K., Takahashi K., Araki W., Maruyama K. and Tabira T. (2000) Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function. J. Biol. Chem. 275, 36813686.
  • Shirotani K., Edbauer D., Capell A., Schmitz J., Steiner H. and Haass C. (2003) Gamma-secretase activity is associated with a conformational change of nicastrin. J. Biol. Chem. 278, 16 47416 477.
  • Shirotani K., Edbauer D., Kostka M., Steiner H. and Haass C. (2004) Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1. J. Neurochem. 89, 15201527.
  • Shoji M., Golde T. E., Ghiso J. et al. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126129.
  • Siman R., Reaume A. G., Savage M. J., Trusko S., Lin Y. G., Scott R. W. and Flood D. G. (2000) Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J. Neurosci. 20, 87178726.
  • Singh N., Talalayeva Y., Tsiper M. et al. (2001) The role of Alzheimer's disease-related presenilin 1 in intercellular adhesion. Exp. Cell Res. 263, 113.
  • Stahl B., Diehlmann A. and Sudhof T. C. (1999) Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. J. Biol. Chem. 274, 91419148.
  • Steiner H., Capell A., Pesold B., Citron M., Kloetzel P. M., Selkoe D. J., Romig H., Mendla K. and Haass C. (1998) Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273, 32 32232 331.
  • Steiner H., Romig H., Grim M. G., Philipp U., Pesold B., Citron M., Baumeister R. and Haass C. (1999a) The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J. Biol. Chem. 274, 76157618.
  • Steiner H., Romig H., Pesold B., Philipp U., Baader M., Citron M., Loetscher H., Jacobsen H. and Haass C. (1999b) Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry 38, 14 60014 605.
  • Steiner H., Duff K., Capell A. et al. (1999c) A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J. Biol. Chem. 274, 28 66928 673.
  • Steiner H., Kostka M., Romig H. et al. (2000) Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nat. Cell Biol. 2, 848851.
  • Steiner H., Winkler E., Edbauer D., Prokop S., Basset G., Yamasaki A., Kostka M. and Haass C. (2002) PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277, 39 06239 065.
  • Stewart W. F., Kawas C., Corrada M. and Metter E. J. (1997) Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626632.
  • Struhl G. and Greenwald I. (2001) Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. Proc. Natl Acad. Sci. USA 98, 229234.
  • Takashima A., Murayama M., Murayama O. et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. PG-9637-41. Proc Natl Acad. Sci. USA 95, 96379641.
  • Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G. and Iwatsubo T. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422, 438441.
  • Tesco G. and Tanzi R. E. (2000) GSK3 beta forms a tetrameric complex with endogenous PS1-CTF/NTF and beta-catenin. Effects of the D257/D385A and FAD-linked mutations. Ann. NY Acad. Sci. 920, 227232.
  • Thinakaran G., Borchelt D. R., Lee M. K. et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181190.
  • Thinakaran G., Harris C. L., Ratovitski T., Davenport F., Slunt H. H., Price D. L., Borchelt D. R. and Sisodia S. S. (1997) Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272, 28 41528 422.
  • Thinakaran G., Regard J. B., Bouton C. M., Harris C. L., Price D. L., Borchelt D. R. and Sisodia S. S. (1998) Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4, 438453.
  • Tian L., Nyman H., Kilgannon P., Yoshihara Y., Mori K., Andersson L. C., Kaukinen S., Rauvala H., Gallatin W. M. and Gahmberg C. G. (2000) Intercellular adhesion molecule-5 induces dendritic outgrowth by homophilic adhesion. J. Cell Biol. 150, 243252.
  • Tomita S., Ozaki T., Taru H., Oguchi S., Takeda S., Yagi Y., Sakiyama S., Kirino Y. and Suzuki T. (1999a) Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem. 274, 22432254.
  • Tomita T., Takikawa R., Koyama A., Morohashi Y., Takasugi N., Saido T. C., Maruyama K. and Iwatsubo T. (1999b) C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin. J. Neurosci. 19, 10 62710 634.
  • Tomita T., Watabiki T., Takikawa R., Morohashi Y., Takasugi N., Kopan R., De Strooper B. and Iwatsubo T. (2001) The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilins. J. Biol. Chem. 276, 33 27333 281.
  • Tomita T., Katayama R., Takikawa R. and Iwatsubo T. (2002) Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments. FEBS Lett. 520, 117121.
  • In T′Veld B. A., Ruitenberg A., Hofman A., Launer L. J., Van Duijn C. M., Stijnen T., Breteler M. M. and Stricker B. H. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 345, 15151521.
  • Verdile G., Martins R. N., Duthie M., Holmes E., St George-Hyslop P. H. and Fraser P. E. (2000) Inhibiting amyloid precursor protein C-terminal cleavage promotes an interaction with presenilin 1. J. Biol. Chem. 275, 20 79420 798.
  • Vito P., Lacana E. and D'Adamio L. (1996a) Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521525.
  • Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacana E. and D'Adamio L. (1996b) Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271, 31 02531 028.
  • Vito P., Ghayur T. and D'Adamio L. (1997) Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J. Biol. Chem. 272, 28 31528 320.
  • Walker E. S., Martinez M., Brunkan A. L. and Goate A. M. (2005) Presenilin 2 FAD mutations result in partial loss of function and dramatic changes in Aβ 42/40 ratios. J. Neurochem. 92, 294301.
  • Walter J., Capell A., Grunberg J. et al. (1996) The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2, 673691.
  • Walter J., Grunberg J., Capell A. et al. (1997) Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C. Proc. Natl Acad. Sci. USA 94, 53495354.
  • Walter J., Schindzielorz A., Grunberg J. and Haass C. (1999) Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl Acad. Sci. USA 96, 13911396.
  • Wang J., Brunkan A. L., Hecimovic S., Walker E. and Goate A. (2004) Conserved ‘PAL’ sequence in presenilins is essential for gamma-secretase activity, but not required for formation or stabilization of gamma-secretase complexes. Neurobiol. Dis. 15, 654666.
  • Wang R., Sweeney D., Gandy S. E. and Sisodia S. S. (1996) The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271, 31 89431 902.
  • Weggen S., Eriksen J. L., Das P. et al. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212216.
  • Weggen S., Eriksen J. L., Sagi S. A., Pietrzik C. U., Golde T. E. and Koo E. H. (2003a) Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J. Biol. Chem. 278, 30 74830 754.
  • Weggen S., Eriksen J. L., Sagi S. A., Pietrzik C. U., Ozols V., Fauq A., Golde T. E. and Koo E. H. (2003b) Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J. Biol. Chem. 278, 31 83131 837.
  • Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C. L. and Beyreuther K. (1997) Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein. Nat. Med. 3, 328332.
  • Weidemann A., Eggert S., Reinhard F. B., Vogel M., Paliga K., Baier G., Masters C. L., Beyreuther K. and Evin G. (2002) A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 28252835.
  • Weihofen A., Binns K., Lemberg M. K., Ashman K. and Martoglio B. (2002) Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296, 22152218.
  • Weihofen A., Lemberg M. K., Friedmann E., Rueeger H., Schmitz A., Paganetti P., Rovelli G. and Martoglio B. (2003) Targeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitors. J. Biol. Chem. 278, 16 52816 533.
  • Westlund B., Parry D., Clover R., Basson M. and Johnson C. D. (1999) Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel-12 and hop-1 in Notch-pathway signaling. Proc. Natl Acad. Sci. USA 96, 24972502.
  • Wiltfang J., Esselmann H., Cupers P. et al. (2001) Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J. Biol. Chem. 276, 42 64542 657.
  • Wolfe M. S., Citron M., Diehl T. S., Xia W., Donkor I. O. and Selkoe D. J. (1998) A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity. J. Med. Chem. 41, 69.
  • Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999a) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513517.
  • Wolfe M. S., Xia W., Moore C. L., Leatherwood D. D., Ostaszewski B., Rahmati T., Donkor I. O. and Selkoe D. J. (1999b) Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38, 47204727.
  • Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W. and D'Adamio L. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 17101713.
  • Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J., Trumbauer M. E., Chen H. Y., Price D. L., Van der Ploeg L. H. and Sisodia S. S. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387, 288292.
  • Xia W., Zhang J., Perez R., Koo E. H. and Selkoe D. J. (1997a) Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 82088213.
  • Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M. B., Teplow D. B., Haass C., Seubert P., Koo E. H. and Selkoe D. J. (1997b) Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272, 79777982.
  • Xia W., Zhang J., Ostaszewski B. L., Kimberly W. T., Seubert P., Koo E. H., Shen J. and Selkoe D. J. (1998) Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi. Biochemistry 37, 16 46516 471.
  • Xia W., Ray W. J., Ostaszewski B. L., Rahmati T., Kimberly W. T., Wolfe M. S., Zhang J., Goate A. M. and Selkoe D. J. (2000) Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. Proc. Natl Acad. Sci. USA 97, 92999304.
  • Xia X., Qian S., Soriano S., Wu Y., Fletcher A. M., Wang X. J., Koo E. H., Wu X. and Zheng H. (2001) Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc. Natl Acad. Sci. USA 98, 10 86310 868.
  • Xia X., Wang P., Sun X., Soriano S., Shum W. K., Yamaguchi H., Trumbauer M. E., Takashima A., Koo E. H. and Zheng H. (2002) The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. Proc. Natl Acad. Sci. USA 99, 87608765.
  • Xu X., Shi Y., Wu X., Gambetti P., Sui D. and Cui M. Z. (1999) Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1. J. Biol. Chem. 274, 32 54332 546.
  • Yang D. S., Tandon A., Chen F. et al. (2002) Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J. Biol. Chem. 277, 28 13528 142.
  • Yu C., Kim S. H., Ikeuchi T., Xu H., Gasparini L., Wang R. and Sisodia S. S. (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 43 75643 760.
  • Yu G., Chen F., Levesque G. et al. (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J. Biol. Chem. 273, 16 47016 475.
  • Yu G., Chen F., Nishimura M. et al. (2000a) Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes. J. Biol. Chem. 275, 2734827353.
  • Yu G., Nishimura M., Arawaka S. et al. (2000b) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407, 4854.
  • Zaidi N., Berezovska O., Choi E., Miller J., Chan H., Lilliehook C., Hyman B., Buxbaum J. and Wasco W. (2002) Biochemical and immunocytochemical characterization of calsenilin in mouse brain. Neuroscience 114, 247.
  • Zandi P. P., Anthony J. C., Hayden K. M., Mehta K., Mayer L. and Breitner J. C. (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59, 880886.
  • Zhang J., Kang D. E., Xia W., Okochi M., Mori H., Selkoe D. J. and Koo E. H. (1998a) Subcellular distribution and turnover of presenilins in transfected cells. J. Biol. Chem. 273, 12 43612 442.
  • Zhang J., Ye W., Wang R., Wolfe M. S., Greenberg B. D. and Selkoe D. J. (2002) Proteolysis of chimeric beta-amyloid precursor proteins containing the Notch transmembrane domain yields amyloid beta-like peptides. J. Biol. Chem. 277, 15 06915 075.
  • Zhang L., Song L., Terracina G., Liu Y., Pramanik B. and Parker E. (2001) Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides. Biochemistry 40, 50495055.
  • Zhang Z., Hartmann H., Do V. M. et al. (1998b) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698702.
  • Zhou J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M. and Kosik K. S. (1997) Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8, 20852090.